Zoetis Inc
Closed
SectorHealthcare
78.07 1.63
Overview
Share price change
24h
Min
76.41
Max
79.02
Income | -2M 601M |
|---|---|
Sales | -125M 2.3B |
P/E Sector Avg | 12.441 50.958 |
EPS | 1.42 |
Dividend yield | 2.58 |
Profit margin | 26.569 |
Employees | 14,500 |
EBITDA | -8M 939M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +52.29% upside |
Dividend yield Sector Avg | 2.58% 2.41% |
|---|---|
Next Earnings | 4 sie 2026 |
Next Dividend date | 1 wrz 2026 |
Next Ex Dividend date | 20 lip 2026 |
Market Cap | -16B 32B |
|---|---|
Previous open | 76.44 |
Previous close | 78.07 |
News Sentiment
By Acuity
56%
44%
275 / 342 Ranking in Healthcare
Zoetis Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
About Zoetis Inc
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.